25/07/2024
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
25/07/2024
Jul 25, 2024, 12:20 |
Blog
Zainab Shinkafi-Bagudu: Consultant job at Gavi, the Vaccine Alliance
Zainab Shinkafi-Bagudu posted on LinkedIn: "Are you a fit? .…
Jul 25, 2024, 12:07 |
Insight
Sonia Guedan: CAR affinity modulates CAR-T cells' sensitivity to PD-1/PD-L1 inhibition
Sonia Guedan, shared a post on X about a recent paper titled "CAR affinity modulates the…
Jul 25, 2024, 12:01 |
Blog
Sendurai Mani: United Steps - Raising Cancer Awareness through Urban Hikes
Sendurai Mani shared a post on LinkedIn: . "United Steps: Raising Cancer Awareness through Urban…
Jul 25, 2024, 11:55 |
Blog
European School of Oncology - The 2023 ESMO guidelines for early breast cancer diagnosis, treatment, and follow-up
European School of Oncology shared on LinkedIn: "Stay up-to-date with our e-Session 'The 2023 ESMO guidelines…
Jul 25, 2024, 11:47 |
Opinion
Melissa Codio Smith: MD Anderson Cancer Center's Project Valet offers Free Mammograms to uninsured patients
Melissa Codio Smith, Executive Director Of Operations at Shifa Healthcare and Community Services, posted on LinkedIn:…
Jul 25, 2024, 11:37 |
Insight
World Hepatitis Day by European Cancer Organisation
European Cancer Organisation (ECO) shared a post on X: “On World Hepatitis Day this 28…
Jul 25, 2024, 11:12 |
Societies
8 Posts From ANZUP24 That You Should Not Miss!
Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) organized their ANZUP24 Annual…
Jul 25, 2024, 11:11 |
Immune Oncology
Immunotherapy for Blood Cancer
Introduction to Blood Cancer Blood cancers, also known as hematologic cancers, affect the production and…
Jul 25, 2024, 08:58 |
Insight
Marleen Kok: How do we get from one-size-fits-all to personalized treatment for TNBC
Marleen Kok, Breast Medical Oncologist at the Netherlands Cancer Institute, shared on X: "Today from…
Jul 25, 2024, 08:49 |
Blog
Earle Burgess: Another interesting new drug in development for metastatic castrate resistant prostate cancer
Earle Burgess, Genitourinary Medical Oncologist at Atrium Health, Levine Cancer Institute, shared on LinkedIn: ''ARV-766: another…
1
2
3
4
5
All:
93
Posts:
21 - 30
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Our commitment to seek all possible pathways to make BOT/BAL available to patients is unwavering: Steven O'Day, Agenus CMO
Facebook
RSS Feed
Twitter
Linkedin
Youtube